Impact of hepatitis C virus co-infection on HIV patients before and after highly active antiretroviral therapy: an immunological and clinical chemistry observation, Addis Ababa, Ethiopia

Table 3 Mean baseline and fourth year CD4 ⁺ and CD8 ⁺ cell count of HIV/HCV co-infected under HAART and pre-ART patients

Cells/μl	Year	HIV/HCV co-infected (G2) under HAART (n = 16) Mean ± SD	HIV mono-infected (G4) pre-ART (n = 9) Mean ± SD	p value
CD4⁺	1^st year	148 ± 30	303 ± 73	P < 0.001
CD4⁺	4^th year	343 ± 119	211 ± 163	P < 0.004
CD8⁺	1^st year	1104 ± 420	1612 ± 380	P < 0.003
	4^th year	1259 ± 430	772 ± 552	P < 0.003

(Number of patients in parenthesis), N/S- not significant.
Key: G = Group, HAART = highly active antiretroviral therapy, ART = Antiretroviral treatment, μl = microliter, CD = Cluster designation/differentiation, SD = standard deviation.

ISSN: 1471-2172